Abbott Laboratories Probes Two Cyber Incidents Amid Extortion Claims

Abbott Laboratories is investigating two concurrent cybersecurity incidents: unauthorized access to legacy systems belonging to Exact Sciences within its Cancer Diagnostics unit and an extortion claim asserting data theft from Abbott's LabCentral portal. Both matters remain under investigation, carry significant HIPAA, SEC and state notification implications if patient or corporate data were exfiltrated, and exemplify the growing trend of financially motivated extortion against healthcare organizations relying on legacy infrastructure.